EMMAUS LIFE SCIENCES, INC.·4/A

Oct 11, 9:17 AM ET

NAGASAKI YASUSHI 4/A

4/A · EMMAUS LIFE SCIENCES, INC. · Filed Oct 11, 2011

Insider Transaction Report

Form 4/AAmended
Period: 2011-06-29
NAGASAKI YASUSHI
Chief Financial Officer
Transactions
  • Other

    Convertible Promissory Note

    2011-06-29$360000.00/sh100,000 total
    Exercise: $3.60From: 2011-06-29Exp: 2012-06-29Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]This amendment is being filed to correct the number of Convertible Shares previously reported and to include the interest rate on the Convertible Promissory Note.
  • [F2]The principal amount of the Convertible Promissory Note plus unpaid accrued interest (8% per annum) is convertible into shares of the Issuer's common stock. The 100,000 shares represents the number of shares into which the principal amount of the Convertible Promissory Note may be converted (the "Convertible Shares').

Documents

1 file
  • 4
    doc1.xml

    FORM 4/A